Consistent with previous studies, CEP55 expression in cancer tissues was significantly higher than its expression in healthy tissues in most of the cancers analyzed, especially in BRCA, GBM, HNSC, LUAD, PAAD, and UCEC with abnormally active CEP55 mRNA and protein levels. Here, CEP55 is linked to glioblastoma.